|
|
N/A
|
ACN12001-001
|
$270
|
-, -
|
NASA/JPL JET PROPULSION LABORA
|
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
5R01CA205632-03
|
$457,974
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
|
(PQA5) Dose and Mechanisms of Exercise in Breast Cancer Prevention
|
5R01CA179992-05
|
$648,503
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
00005I-0140 NCI-OD -- 8422873
|
271201800005I
|
$43,698
|
N/A
|
KELLY SERVICES INC
|
|
|
00007I-4739 NCI-OD -- 8422873
|
271201500007I
|
$24,553
|
N/A
|
KELLY SERVICES INC
|
|
|
00012I-0329 NCI-OD -- 8422873
|
271201800012I
|
$137,572
|
N/A
|
KELLY SERVICES INC
|
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048377-25
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048381-25
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048468-25
|
$68,181
|
FURLONG, KEVIN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048434-25
|
$68,181
|
GOLDBERG, RONALD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) - Phase 3 - Research Project
|
5U01DK048514-25
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048375-25
|
$68,181
|
DABELEA, DANA
|
UNIVERSITY OF COLORADO DENVER
|
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048413-25
|
$68,181
|
KAHN, STEVEN
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048411-25
|
$58,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
|
10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
|
5U01DK048380-25
|
$68,181
|
MOLITCH, MARK
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048397-25
|
$68,181
|
NATHAN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
13/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048404-25
|
$68,181
|
PI-SUNYER, XAVIER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
14/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048406-25
|
$68,181
|
MATHER, KIEREN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
15-PGDH in Cholangiocarcinogenesis
|
5R01CA102325-12
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
15/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048387-25
|
$68,181
|
MAGEE, MICHELLE
|
MEDSTAR HEALTH RESEARCH INSTITUTE
|
|
|
16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048443-25
|
$68,181
|
WATSON, KAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
17/22 DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) PHASE 3 - RESEARCH PROJECT
|
5U01DK048400-25
|
$22,085
|
BROWN, ANGELA
|
WASHINGTON UNIVERSITY
|
|
|
18/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Project
|
5U01DK048485-25
|
$68,181
|
GOLDEN, SHERITA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
19/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048407-25
|
$44,000
|
SCHADE, DAVID
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048349-26
|
$68,181
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
2015 Radiation Epidemiology Course
|
ZIA CP010131 10596
|
$30,751
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
2018 SEER ADVANCED TOPICS FOR REGISTRY PROFESSIONALS WORKSHOP
|
261201800246P
|
$25,000
|
ALLEN, NANCY
|
NATIONAL CANCER REGISTRAR'S ASSOCIATION
|
|
|
21/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048412-25
|
$68,181
|
VENDITTI, ELIZABETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center
|
5U01DK048489-25
|
$203,538
|
TEMPROSA, MARINELLA
|
GEORGE WASHINGTON UNIVERSITY
|
|
|
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
|
5R01CA194307-03
|
$105,860
|
EISENBREY, JOHN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
|
5R01CA203984-03
|
$669,662
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-03
|
$208,861
|
KAMAYA, AYA
|
STANFORD UNIVERSITY
|
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
5R01CA197516-03
|
$400,610
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
5R01CA174929-05
|
$570,235
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A Case-Control Study of Lung Cancer among Non-smoking Women in Xuan Wei and Fu
|
ZIA CP010121 10349
|
$53,686
|
Lan, Qing
|
DCEG (NCI)
|
|
|
A Chemopreventive Strategy Based on Edible MicroRNAs Produced in Plants
|
1R21CA223353-01
|
$156,514
|
VANCE, VICKI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
|
A clones genomic stability as biomarker of its DNA-damage resilience
|
5K99CA215256-02
|
$166,644
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
|
A cohort mortality study with a nested case-control study of lung cancer and dies
|
ZIA CP010120 02091
|
$582,330
|
Silverman, Debra
|
DCEG (NCI)
|
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$79,723
|
Rothman, Nat
|
DCEG (NCI)
|
|
|
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers
|
5F32CA206247-02
|
$63,034
|
WAGNER, ALEX
|
WASHINGTON UNIVERSITY
|
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-04
|
$49,524
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
|
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
|
1R01CA222871-01
|
$373,547
|
FISHER, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
A Field Test of a Group-delivered Enhancing Connections Program: a Partnership Grant with the Cancer Support Community
|
5R03CA212993-02
|
$77,250
|
LEWIS, FRANCES
|
UNIVERSITY OF WASHINGTON
|
|
|
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
|
5R01CA204093-02
|
$392,078
|
PANDIT-TASKAR, NEETA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$314,516
|
Barchi, Joseph
|
CCR (NCI)
|
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-04
|
$311,458
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
|
5R01CA184173-04
|
$363,342
|
REN, LEI
|
DUKE UNIVERSITY
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$154,883
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
|
A model for predicting response to PD-1 inhibitors in NSCLC
|
5R01CA208403-02
|
$635,258
|
GARON, EDWARD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$106,356
|
Mock, Beverly
|
CCR (NCI)
|
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|
